Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs11037096 | chr11:1649350 | T/C | 2.07E-6 | 472 | 17.07 | 28.57 | 31.38 | KM Plot |
PRAD | rs11038026 | chr11:1668354 | A/G | 0 | 482 | 4.87 | 22.77 | 31.87 | KM Plot |
PRAD | rs11038029 | chr11:1668514 | A/G | 0 | 483 | 4.87 | 22.43 | 32.03 | KM Plot |
PRAD | rs11038129 | chr11:1671224 | C/T | 0 | 494 | 4.87 | 22.43 | 31.43 | KM Plot |
PRAD | rs11040595 | chr11:49878757 | G/T | 4.49E-6 | 489 | 31.3 | 27.47 | 37.8 | KM Plot |
PRAD | rs1104223 | chr1:201140210 | G/A | 4.51E-6 | 491 | 37.9 | 31.3 | 30.23 | KM Plot |
PRAD | rs11049928 | chr12:9426171 | A/G | 2.4E-9 | 494 | 31.27 | 28.18 | 32.28 | KM Plot |
PRAD | rs11063874 | chr12:723374 | A/T | 0.000142 | 487 | 31.33 | 28.48 | 22.67 | KM Plot |
PRAD | rs11064120 | chr12:768966 | C/T | 7.0E-5 | 494 | 31.32 | 30.23 | 29.95 | KM Plot |
PRAD | rs11072599 | chr15:76774508 | T/C | 8.46E-5 | 493 | 28.3 | 31.87 | 30.87 | KM Plot |
PRAD | rs11087717 | chr20:6091175 | T/G | 7.75E-6 | 493 | 31.23 | 29.05 | 31.77 | KM Plot |
PRAD | rs11087718 | chr20:6091183 | T/C | 7.75E-6 | 493 | 31.23 | 29.05 | 31.77 | KM Plot |
PRAD | rs11089210 | chr22:18445692 | A/T | 1.4E-6 | 491 | 30.9 | 31.65 | 26.37 | KM Plot |
PRAD | rs1110659 | chr22:18444675 | T/C | 3.96E-6 | 494 | 30.8 | 31.87 | 26.37 | KM Plot |
PRAD | rs1110660 | chr22:18444693 | A/C | 3.96E-6 | 494 | 30.8 | 31.87 | 26.37 | KM Plot |